Clinical trials for Hepatitis b, chronic investigate a range of treatment strategies and patient populations.

16 total trials for this combination

Showing top 10 of 16 trials

Trials

NCT ID	Title	Status	Phase
NCT01011738	An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys	COMPLETED	—
NCT03866187	Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection	TERMINATED	PHASE1/PHASE2
NCT01163240	Epidemiological Study in Children and Adolescents With Chronic Hepatitis B	COMPLETED	—
NCT00435825	A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B (CHB).	COMPLETED	PHASE4
NCT05630820	Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)	ACTIVE_NOT_RECRUITING	PHASE3
NCT01855997	A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B (CHB) Who Received Treatment With Pegasys (Peginterferon Alfa-2a) ± Nucleoside/Nucleotide Analogue	COMPLETED	—
NCT04585165	User-friendly HIV Testing and Counseling Services	UNKNOWN	—
NCT03982186	A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection	COMPLETED	PHASE2
NCT04225715	A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B	COMPLETED	PHASE2
NCT05276297	A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy	COMPLETED	PHASE2

Related Pages

All Hepatitis b, chronic trials All trials in Chiang Mai, Thailand